HALO Link

Indica Labs’ Pharma Services Launches GCP-Compliant Image Analysis Service

Albuquerque, NM, July 8, 2025 – Indica Labs, the global leader in AI-powered digital pathology software and services, today announces that their Pharma Services team is offering quantitative image analysis studies designed and performed to Good Clinical Practice (GCP) standards.

Indica Labs’ Pharma Services Launches GCP-Compliant Image Analysis Service Read More »

Indica Labs and Visiopharm Deliver an Integrated Digital Pathology Image Management and Analysis Solution

Albuquerque, NM and Hørsholm, Denmark, April 9, 2025 – Indica Labs and Visiopharm today announce the successful integration of Visiopharm’s Discovery image analysis software into Indica’s collaborative image management platform, HALO Link. The integration will enable laboratories to create a customized digital pathology ecosystem optimized for their unique image analysis and collaboration needs.

Indica Labs and Visiopharm Deliver an Integrated Digital Pathology Image Management and Analysis Solution Read More »

HALO®, HALO AI, and HALO Link 4.1 Features and Functionalities

In this blog post, you can learn about some of the new features in the 4.1 release including the new High Dimensional Analysis module, when to expect your chance to upgrade, and where to find user guides, release notes, and tutorial videos.

HALO®, HALO AI, and HALO Link 4.1 Features and Functionalities Read More »

Indica Labs’ Boston HALO® User Group Meeting

15 May 2025 | Indica Labs is pleased to announce our Boston HALO® User Group Meeting at Le Méridien Boston Cambridge on May 15 from 9:30 am – 4 pm.

Indica Labs’ Boston HALO® User Group Meeting Read More »

Open Pathology and AI Integrations: Empowering Labs with Choice

In digital pathology, advancements and proliferation in artificial intelligence (AI) and digital laboratory equipment are enabling streamlined workflows and new insights. However, they can also multiply the potential challenges laboratories face with software integration.

Open Pathology and AI Integrations: Empowering Labs with Choice Read More »

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform

Vista, CA, and Albuquerque, NM, January 8, 2025 – Leica Biosystems, a global leader in anatomic and digital pathology solutions, and Indica Labs, a global leader in artificial intelligence (AI)-powered digital pathology software, today announced that Leica Biosystems has agreed to make a significant strategic investment in Indica Labs. This partnership has the potential to accelerate AI-enabled companion diagnostics (CDx) and support discoveries and treatments based on discrete or complex biomarker expression profiles which are not discernable by the human eye.

Leica Biosystems and Indica Labs Announce Significant Strategic Investment and Creation of Digital Pathology Platform Read More »

Scroll to Top